New Releases


Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
10/03/18Optinose to Highlight Data at Two Upcoming Scientific MeetingsPrinter Friendly Version
09/24/18Optinose to Present at the 2018 Cantor Global Healthcare ConferencePrinter Friendly Version
08/14/18Optinose Reports Second Quarter 2018 Financial Results and Recent Operational HighlightsPrinter Friendly Version
08/07/18Optinose to Report Second Quarter 2018 Financial Results and Corporate Updates on August 14, 2018Printer Friendly Version
07/02/18Optinose Named a 2018 Best Place to Work by Philadelphia Business JournalPrinter Friendly Version
06/21/18Optinose Announces Publication of Pivotal Efficacy and Long-Term Safety Data for XHANCE in Peer Reviewed JournalsPrinter Friendly Version
06/15/18Optinose CEO Peter Miller and President and COO Ramy Mahmoud Named EY Life Sciences Entrepreneur Of The Year 2018 in GreaterPrinter Friendly Version
06/11/18Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common SharesPrinter Friendly Version
06/06/18Optinose Announces Pricing of Public Offering of Common StockPrinter Friendly Version
06/04/18Optinose Announces Launch of Public Offering of Common StockPrinter Friendly Version
05/14/18Optinose Reports First Quarter 2018 Financial Results and Recent Operational HighlightsPrinter Friendly Version
05/07/18Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018Printer Friendly Version
04/23/18Optinose CEO Peter Miller and President/COO Ramy Mahmoud Named EY Entrepreneur of the Year 2018 Finalists in the Greater Philadelphia AreaPrinter Friendly Version
03/15/18Optinose Named Emerging Company of the Year by Life Sciences PennsylvaniaPrinter Friendly Version
03/13/18Optinose Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational HighlightsPrinter Friendly Version
03/06/18Optinose to Report Fourth Quarter and Full Year 2017 Financial Results and Corporate Updates on March 13, 2018Printer Friendly Version
02/27/18Optinose to Highlight Data at the 2018 AAAAI/WAO Joint CongressPrinter Friendly Version
02/22/18Optinose names Sandra L. Helton as Director and Chairperson of the Company’s Audit CommitteePrinter Friendly Version
02/20/18Peter Miller Named Frank Baldino Bioscience CEO of the Year by Life Sciences PennsylvaniaPrinter Friendly Version
02/15/18Optinose to Present at the 2018 RBC Capital Markets Healthcare ConferencePrinter Friendly Version
02/09/18Optinose to Present at Leerink Partners 7th Annual Global Healthcare ConferencePrinter Friendly Version
01/02/18Optinose Announces $100 Million Debt Financing from Athyrium Capital ManagementPrinter Friendly Version